MHE Staff

Articles by MHE Staff

The American Council of Life Insurers (ACLI) senior vice president of Policy Development, Paul Graham, recently responded to the social media news which suggested COVID-19 vaccines could be a factor a life insurer considers in the claims-paying process.

Market research firm sees growth in sales for injectable therapies developed with an eye toward improving adherence. Sales in pre-exposure prophylaxis are also projected to increase.

Aetna got out of the ACA marketplace business in 2018. Now CVS Health, which completed its acquisition of the insurance company in late 2018, is hopping back in and will brand the policies as a “CVS Health-Aetna” product for the first time.

The Trump administration didn’t get very far with healthcare reform; the ACA was neither repealed nor replaced. But former CMS Administrator Seema Verma made a run at revamping Medicaid by using Section 1115 waivers to add working requirements. Now the Biden administration is taking steps to stop the requirements before they get started.

More than one out of every 10 seniors enrolled in a Medicare Advantage plan and living in a rural area switched to traditional Medicare in the last few years, prior to the pandemic. The switch was driven primarily due to low satisfaction with care access, according to a study recently published in Health Affairs from researchers at Drexel University’s Dornsife School of Public Health.

Dark skin is significantly underrepresented in medical literature and curricula, comprising an average of just 4.5% of images in medical textbooks. In response, clinicians of all licensures and specialties are often insufficiently trained to recognize disease patterns in patients of color. To confront this issue, Project IMPACT was created to raise awareness and adoption of educational and clinical resources and solutions that strengthen clinicians’ ability to accurately diagnose disease in black and brown skin and improve health equity.

Woodcock is seen as more pro-industry and favored by patient advocacy groups. Sharfstein's supporters say he would restore integrity to the agency. Sharfstein has proposed reforms to the FDA approval process.